As of 2025-11-05, the Relative Valuation of 4D Molecular Therapeutics Inc (FDMT) is (82.01) USD. This relative valuation is based on P/E multiples. With the latest stock price at 10.51 USD, the upside of 4D Molecular Therapeutics Inc based on Relative Valuation is -880.3%.
The range of the Relative Valuation is (64.26) - (99.96) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.3x - 23.8x | 19.6x |
| Forward P/E multiples | 15.2x - 23.8x | 19.5x |
| Fair Price | (64.26) - (99.96) | (82.01) |
| Upside | -711.4% - -1051.1% | -880.3% |
| Date | P/E |
| 2025-10-30 | -2.65 |
| 2025-10-29 | -2.72 |
| 2025-10-28 | -2.85 |
| 2025-10-27 | -2.92 |
| 2025-10-24 | -2.70 |
| 2025-10-23 | -2.38 |
| 2025-10-22 | -2.50 |
| 2025-10-21 | -2.68 |
| 2025-10-20 | -2.68 |
| 2025-10-17 | -2.34 |
| 2025-10-16 | -2.40 |
| 2025-10-15 | -2.37 |
| 2025-10-14 | -2.37 |
| 2025-10-13 | -2.30 |
| 2025-10-10 | -2.12 |
| 2025-10-09 | -2.28 |
| 2025-10-08 | -2.30 |
| 2025-10-07 | -1.98 |
| 2025-10-06 | -2.00 |
| 2025-10-03 | -2.04 |
| 2025-10-02 | -2.06 |
| 2025-10-01 | -2.08 |
| 2025-09-30 | -2.07 |
| 2025-09-29 | -1.99 |
| 2025-09-26 | -2.00 |
| 2025-09-25 | -2.00 |
| 2025-09-24 | -2.01 |
| 2025-09-23 | -1.81 |
| 2025-09-22 | -1.76 |
| 2025-09-19 | -1.57 |
| 2025-09-18 | -1.69 |
| 2025-09-17 | -1.59 |
| 2025-09-16 | -1.59 |
| 2025-09-15 | -1.62 |
| 2025-09-12 | -1.62 |
| 2025-09-11 | -1.68 |
| 2025-09-10 | -1.65 |
| 2025-09-09 | -1.66 |
| 2025-09-08 | -1.66 |
| 2025-09-05 | -1.73 |
| 2025-09-04 | -1.57 |
| 2025-09-03 | -1.54 |
| 2025-09-02 | -1.46 |
| 2025-08-29 | -1.47 |
| 2025-08-28 | -1.47 |
| 2025-08-27 | -1.54 |
| 2025-08-26 | -1.55 |
| 2025-08-25 | -1.60 |
| 2025-08-22 | -1.69 |
| 2025-08-21 | -1.63 |